US EditionPublished • loading... • Updated
Insulet promotes from within to fill CTO role
Summary by Drug Delivery Business
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Insulet promotes from within to fill CTO role
Amit Guliani. [Image courtesy of Insulet]Insulet (Nasdaq:PODD) announced today that it appointed Amit Guliani as its chief technology officer (CTO). Guliani’s appointment follows a nearly six-month tenure as acting CTO at the Acton, Massachusetts-based insulin pump maker. He took over in the interim role after Mark Field announced his departure in March. Previously, Guliani served as group VP, software engineering. He joined Insulet in 2023 and …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
